Submitted by Anonymous (not verified) on 26 February 2025 - 9:16
Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals
Source:
Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals